Bhat M - Search Results

1

The mTOR pathway in hepatic malignancies.

Bhat M, Sonenberg N, Gores GJ. Bhat M, et al. Hepatology. 2013 Aug;58(2):810-8. doi: 10.1002/hep.26323. Epub 2013 Apr 17. Hepatology. 2013. PMID: 23408390 Free PMC article. Review.

2

eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.

Alain T, Morita M, Fonseca BD, Yanagiya A, Siddiqui N, Bhat M, Zammit D, Marcus V, Metrakos P, Voyer LA, Gandin V, Liu Y, Topisirovic I, Sonenberg N. Alain T, et al. Among authors: bhat m. Cancer Res. 2012 Dec 15;72(24):6468-76. doi: 10.1158/0008-5472.CAN-12-2395. Epub 2012 Oct 24. Cancer Res. 2012. PMID: 23100465

3

Metformin does not improve survival in patients with hepatocellular carcinoma.

Bhat M, Chaiteerakij R, Harmsen WS, Schleck CD, Yang JD, Giama NH, Therneau TM, Gores GJ, Roberts LR. Bhat M, et al. World J Gastroenterol. 2014 Nov 14;20(42):15750-5. doi: 10.3748/wjg.v20.i42.15750. World J Gastroenterol. 2014. PMID: 25400459 Free PMC article.

4

Targeting the translation machinery in cancer.

Bhat M, Robichaud N, Hulea L, Sonenberg N, Pelletier J, Topisirovic I. Bhat M, et al. Nat Rev Drug Discov. 2015 Apr;14(4):261-78. doi: 10.1038/nrd4505. Epub 2015 Mar 6. Nat Rev Drug Discov. 2015. PMID: 25743081 Review.

5

Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk?

Bhat M, Watt KD. Bhat M, et al. Clin Transplant. 2015 Jul;29(7):654-63. doi: 10.1111/ctr.12559. Epub 2015 Jun 10. Clin Transplant. 2015. PMID: 26094583 Review.

6

Portal vein encasement predicts neoadjuvant therapy response in liver transplantation for perihilar cholangiocarcinoma protocol.

Bhat M, Hathcock M, Kremers WK, Darwish Murad S, Schmit G, Martenson J, Alberts S, Rosen CB, Gores GJ, Heimbach J. Bhat M, et al. Transpl Int. 2015 Dec;28(12):1383-91. doi: 10.1111/tri.12640. Epub 2015 Aug 6. Transpl Int. 2015. PMID: 26183487 Free article.

7

Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics.

Bhat M, Ghali P, Dupont B, Hilzenrat R, Tazari M, Roy A, Chaudhury P, Alvarez F, Carrier M, Bilodeau M. Bhat M, et al. J Hepatol. 2017 Feb;66(2):374-381. doi: 10.1016/j.jhep.2016.10.008. Epub 2016 Oct 15. J Hepatol. 2017. PMID: 27751840

8

Reply to: "Proposal of a novel MELD exception point system for hepatocellular carcinoma: Dynamics better than tumor characteristics?".

Bhat M, Ghali P, Bilodeau M. Bhat M, et al. J Hepatol. 2017 Jul;67(1):199-200. doi: 10.1016/j.jhep.2017.03.019. Epub 2017 Mar 24. J Hepatol. 2017. PMID: 28347800 No abstract available.

9

Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells.

Bhat M, Yanagiya A, Graber T, Razumilava N, Bronk S, Zammit D, Zhao Y, Zakaria C, Metrakos P, Pollak M, Sonenberg N, Gores G, Jaramillo M, Morita M, Alain T. Bhat M, et al. Oncotarget. 2016 Jul 18;8(31):50542-50556. doi: 10.18632/oncotarget.10671. eCollection 2017 Aug 1. Oncotarget. 2016. PMID: 28881582 Free PMC article.

10

Canadian liver transplant allocation for hepatocellular carcinoma.

Brahmania M, Marquez V, Kneteman NM, Bhat M, Marleau D, Wong P, Peletekian KM, Burak KW, Congly SE. Brahmania M, et al. Among authors: bhat m. J Hepatol. 2019 Nov;71(5):1058-1060. doi: 10.1016/j.jhep.2019.07.016. Epub 2019 Sep 5. J Hepatol. 2019. PMID: 31495534 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,668 results

Search Page

Filters